Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Bhatia

Blood

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Blood|November 8, 2014
Leukemia cells make ruthless competitorsRavi Bhatia
Blood|December 7, 2007
Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606Heiko Konig, Tessa L Holyoake, Ravi Bhatia
Blood|April 9, 2004
BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cellsSu Chu, Melissa Holtz, Mamta Gupta, et al.
Blood|March 7, 2015
Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia developmentMarisa Bowers, Bin Zhang, Yinwei Ho, et al.
Blood|June 15, 2011
A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cellsLiang Li, Hardik Modi, Tinisha McDonald, et al.
Blood|March 10, 2007
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cellsHardik Modi, Tinisha McDonald, Su Chu, et al.
Blood|September 21, 2011
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatmentSu Chu, Tinisha McDonald, Allen Lin, et al.
Blood|May 3, 2002
Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferationMelissa S Holtz, Marilyn L Slovak, Feiyu Zhang, et al.
Blood|December 31, 2011
Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesisHongfeng Yuan, Zhiqiang Wang, Ling Li, et al.
Blood|September 4, 2004
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatmentSu Chu, Helen Xu, Neil P Shah, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Blood|November 8, 2014
Leukemia cells make ruthless competitorsRavi Bhatia
Blood|December 7, 2007
Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606Heiko Konig, Tessa L Holyoake, Ravi Bhatia
Blood|April 9, 2004
BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cellsSu Chu, Melissa Holtz, Mamta Gupta, et al.
Blood|March 7, 2015
Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia developmentMarisa Bowers, Bin Zhang, Yinwei Ho, et al.
Blood|June 15, 2011
A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cellsLiang Li, Hardik Modi, Tinisha McDonald, et al.
Blood|March 10, 2007
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cellsHardik Modi, Tinisha McDonald, Su Chu, et al.
Blood|September 21, 2011
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatmentSu Chu, Tinisha McDonald, Allen Lin, et al.
Blood|May 3, 2002
Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferationMelissa S Holtz, Marilyn L Slovak, Feiyu Zhang, et al.
Blood|December 31, 2011
Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesisHongfeng Yuan, Zhiqiang Wang, Ling Li, et al.
Blood|September 4, 2004
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatmentSu Chu, Helen Xu, Neil P Shah, et al.
Pageof 4